Measuring Droplets in Children

Droplet Spread Clinical Trial

— MeDiC  

Official title:

Measuring Droplets in Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04518033
• Other study ID #: 2020P002630
• Status: Completed
• Phase: N/A
• Start date: April 3, 2021
• Est. completion date: April 23, 2021

Study information

• Verified date: January 2022
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will measure the size and quantity of respiratory particle production in children under a variety of conditions, including face coverings/masks and various common activities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 23
• Est. completion date: April 23, 2021
• Est. primary completion date: April 23, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 3 Years to 17 Years

Eligibility

Inclusion Criteria:

• Age 3 to 17 years

Exclusion Criteria:

• Chronic neuromuscular conditions that affect respiration

• Tracheostomy tube

• Unable to wear a face mask

Related Conditions & MeSH terms

• Droplet Spread

Intervention

Device:
• Various commercially available face coverings
Various commercially available face coverings

Locations

Country	Name	City	State
United States	Massachusetts General Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Massachusetts General Hospital	Harvard School of Public Health (HSPH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Respiratory particle production		2 hours